DuPont De Nemours (DD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
Annual meeting scheduled for May 21, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by May 20, 2026, or May 18, 2026, for plan shares.
Voting matters and shareholder proposals
Election of eleven directors, with all nominees recommended by the board.
Advisory vote on executive compensation (say-on-pay) recommended for approval.
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026.
Proposal to amend the Certificate of Incorporation for a reverse stock split and reduction in authorized shares.
Board of directors and corporate governance
Eleven director nominees listed, including Amy G. Brady, Edward D. Breen, and others.
Board recommends voting in favor of all director nominees.
Latest events from DuPont De Nemours
- Q3 net sales up 4%, EBITDA up 11%, and guidance raised as business separations progress.DD
Q3 20249 Jul 2026 - Q4 sales up 7%, EBITDA up 13%, with Electronics separation set for November 1, 2025.DD
Q4 20248 Jul 2026 - Transformation targets 3–4% organic growth, 8–10% EPS CAGR, and strong cash generation by 2028.DD
Investor Day 20258 Jul 2026 - Q3 2025 delivered 7% sales and 6% EBITDA growth, with new share repurchase and portfolio actions.DD
Q3 20258 Jul 2026 - All management proposals, including a reverse stock split, were approved amid strong financial results.DD
AGM 202621 May 2026 - Q1 2026 net sales up 4%, margins and EPS surged, and 2026 guidance was raised.DD
Q1 20265 May 2026 - Board size reduced to ten after a director resignation; all other nominees remain.DD
Proxy filing15 Apr 2026 - 2025 delivered margin expansion and double-digit EPS growth; 2026 outlook strong for sales and cash flow.DD
Q4 202511 Apr 2026 - Annual meeting to vote on directors, pay, auditor, and reverse stock split amid governance focus.DD
Proxy filing10 Apr 2026